Guoshan Ding

2.2k total citations · 1 hit paper
54 papers, 1.6k citations indexed

About

Guoshan Ding is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Guoshan Ding has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 17 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Guoshan Ding's work include Organ Transplantation Techniques and Outcomes (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Immune Cell Function and Interaction (8 papers). Guoshan Ding is often cited by papers focused on Organ Transplantation Techniques and Outcomes (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Immune Cell Function and Interaction (8 papers). Guoshan Ding collaborates with scholars based in China, United States and Hong Kong. Guoshan Ding's co-authors include Xuetao Cao, Jin Hou, Zhengxin Wang, Li Lin, Qian Zhang, Shi‐Mei Zhuang, Limin Zheng, Weiping Zhou, Chunmei Wang and Qiongzhu Dong and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Guoshan Ding

54 papers receiving 1.6k citations

Hit Papers

Identification of miRNomes in Human Liver and Hepatocellu... 2011 2026 2016 2021 2011 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma
    2011 600 citations Guoshan Ding et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoshan Ding China 17 903 777 268 244 229 54 1.6k
Zhongjun Wu China 24 1000 1.1× 669 0.9× 384 1.4× 387 1.6× 336 1.5× 116 1.8k
Ge‐Liang Xu China 23 661 0.7× 354 0.5× 195 0.7× 216 0.9× 215 0.9× 62 1.3k
Bai Ruan China 22 782 0.9× 567 0.7× 169 0.6× 295 1.2× 250 1.1× 33 1.3k
Genshu Wang China 18 669 0.7× 530 0.7× 271 1.0× 297 1.2× 318 1.4× 74 1.6k
Steve F. Bronk United States 16 769 0.9× 388 0.5× 207 0.8× 439 1.8× 298 1.3× 18 1.6k
Yang-Hsiang Lin Taiwan 24 834 0.9× 683 0.9× 101 0.4× 185 0.8× 92 0.4× 59 1.3k
Weihua Ren China 20 661 0.7× 409 0.5× 150 0.6× 160 0.7× 93 0.4× 43 1.1k
Tony W.H. Li United States 27 1.3k 1.4× 364 0.5× 124 0.5× 223 0.9× 102 0.4× 35 1.8k
Jian Gu China 18 652 0.7× 462 0.6× 216 0.8× 154 0.6× 70 0.3× 46 1.1k
Christian D. Fingas Germany 22 653 0.7× 374 0.5× 191 0.7× 447 1.8× 272 1.2× 37 1.7k

Countries citing papers authored by Guoshan Ding

Since Specialization
Citations

This map shows the geographic impact of Guoshan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoshan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoshan Ding more than expected).

Fields of papers citing papers by Guoshan Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoshan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoshan Ding. The network helps show where Guoshan Ding may publish in the future.

Co-authorship network of co-authors of Guoshan Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Guoshan Ding. A scholar is included among the top collaborators of Guoshan Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoshan Ding. Guoshan Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Luo, Yi, Fei Teng, Hong Fu, & Guoshan Ding. (2022). Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons. World Journal of Gastrointestinal Oncology. 14(1). 163–180. 14 indexed citations
5.
6.
Mao, Jia-Xi, et al.. (2020). Pooled analysis of hepatic inflammatory angiomyolipoma. Clinics and Research in Hepatology and Gastroenterology. 44(6). e145–e151. 6 indexed citations
7.
Mao, Jia-Xi, et al.. (2020). Two-in-one: A pooled analysis of primary hepatic neuroendocrine carcinoma combined/collided with hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international. 19(4). 399–403. 7 indexed citations
8.
Song, Shaohua, Fei Teng, Hao Liu, et al.. (2019). Protective effect of salvianolate against bile duct injury after DCD donor liver transplantation. SHILAP Revista de lepidopterología. 44(2). 132–136. 1 indexed citations
9.
Guo, Meng, Shu Han, Yanfang Liu, et al.. (2019). Inhibition of allogeneic islet graft rejection by VISTA-conjugated liposome. Biochemical and Biophysical Research Communications. 516(3). 914–920. 3 indexed citations
10.
Song, Shaohua, Yuanyu Zhao, Fang Liu, et al.. (2019). microRNA-29a regulates liver tumor-initiating cells expansion via Bcl-2 pathway. Experimental Cell Research. 387(2). 111781–111781. 12 indexed citations
11.
Mao, Jia-Xi, et al.. (2019). Two case reports and literature review for hepatic epithelioid angiomyolipoma: Pitfall of misdiagnosis. World Journal of Clinical Cases. 7(8). 972–983. 11 indexed citations
12.
Mao, Jia-Xi, Hang Yuan, Fei Teng, et al.. (2018). A single-center experience of liver transplantation for alcoholic liver disease. Zhonghua gan-dan waike zazhi. 24(3). 150–154. 1 indexed citations
13.
Bao, Leilei, Dongke Zhang, Shu Han, et al.. (2018). MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID. Cellular Physiology and Biochemistry. 47(5). 2046–2055. 16 indexed citations
14.
Zheng, Nanxin, Fang Liu, Hao Lu, et al.. (2017). Schisantherin A protects against liver ischemia-reperfusion injury via inhibition of mitogen-activated protein kinase pathway. International Immunopharmacology. 47. 28–37. 31 indexed citations
15.
Badell, I.R., et al.. (2017). Selective CD28 Blockade Results in Superior Inhibition of Donor-Specific T Follicular Helper Cell and Antibody Responses Relative to CTLA4-Ig. American Journal of Transplantation. 18(1). 89–101. 32 indexed citations
16.
Ding, Guoshan. (2012). Effect of conversion to sirolimus-based immunosuppression on tumor recurrence after liver transplantation for hepatocellular carcinoma beyond the Standard Milan Criteria. Academic Journal of Second Military Medical University. 1 indexed citations
17.
Shi, Xiaomin, Yifeng Tao, Zhiren Fu, et al.. (2011). Reconstruction of the middle hepatic vein tributary in adult right lobe living donor liver transplantation. Hepatobiliary & pancreatic diseases international. 10(6). 581–586. 7 indexed citations
18.
Song, Shaohua, et al.. (2009). A single‐center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma. Clinical Transplantation. 24(6). 752–757. 19 indexed citations
19.
Fu, Hong, Shaohua Song, Fang Liu, et al.. (2009). Dendritic Cells Transduced with SOCS1 Gene Exhibit Regulatory DC Properties and Prolong Allograft Survival. Cellular and Molecular Immunology. 6(2). 87–95. 31 indexed citations
20.
Liang, Xiao, et al.. (2009). Liver transplantation for primary hepatic leiomyosarcoma: a case report and review of the literatures. Medical Oncology. 27(4). 1269–1272. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhongjun Wu Breakdown of academic impact, for papers by Ge‐Liang Xu Breakdown of academic impact, for papers by Bai Ruan Breakdown of academic impact, for papers by Genshu Wang Breakdown of academic impact, for papers by Steve F. Bronk Breakdown of academic impact, for papers by Yang-Hsiang Lin Breakdown of academic impact, for papers by Weihua Ren Breakdown of academic impact, for papers by Tony W.H. Li Breakdown of academic impact, for papers by Jian Gu Breakdown of academic impact, for papers by Christian D. Fingas
Rankless by CCL
2026